Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience

PURPOSE: The enucleation rate for retinoblastoma has dropped from over 95% to under 10% in the past 10 years as a result of improvements in therapy. This reduces access to tumor tissue for molecular profiling, especially in unilateral retinoblastoma, and hinders the confirmation of somatic RB1 mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothari, Prachi, Marass, Francesco, Yang, Julie L., Stewart, Caitlin M., Stephens, Dennis, Patel, Juber, Hasan, Maysun, Jing, Xiaohong, Meng, Fanli, Enriquez, Jeanette, Huberman, Kety, Viale, Agnes, Francis, Jasmine H., Berger, Michael F., Shukla, Neerav, Abramson, David H., Dunkel, Ira J., Tsui, Dana W.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476838/
https://www.ncbi.nlm.nih.gov/pubmed/32633890
http://dx.doi.org/10.1002/cam4.3144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476838/
https://www.ncbi.nlm.nih.gov/pubmed/32633890
http://dx.doi.org/10.1002/cam4.3144

Ejemplares similares